Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11912706 Crystal forms of a POL1 inhibitor

Patent 11912706 was granted and assigned to Pimera, Inc. on February, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Mustapha Haddach0

Date of Patent

February 27, 2024

0

Patent Application Number

164977240

Date Filed

March 28, 2018

0

Patent Citations

US Patent 7507727 Substituted quinobenzoxazine analogs and methods of using thereof

0

US Patent 7612063 Substituted quinobenzoxazine analogs

0

US Patent 7652134 Methods for converting quinolone esters into quinolone amides

0

US Patent 7816406 Quinolone analogs

0

US Patent 7816524 Methods of preparing quinolone analogs

0

US Patent 7928100 Quinolone analogs and methods related thereto

0

US Patent 7998978 Substituted 2-amino-fused heterocyclic compounds

0

US Patent 8142909 Blue phosphorescent imidazophenanthridine materials

0

...

Patent Primary Examiner

0

CPC Code

0

Patent abstract

The present invention relates to novel solid crystalline form of N-methyl-2-(4-methyl-1,4-diazepan-1-yl)benzo [4,5]imidazo[1,2-a][1,8]naphthyridine-6-carbaxomide, processes for the preparation thereof, compositions thereof and method of use thereof.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11912706 Crystal forms of a POL1 inhibitor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool